A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway
Targeting the c-Met signaling pathway has become a therapeutic strategy in multiple types of cancer. We unveiled a novel c-Met regulating mechanism that could be applied as a modality for oral squamous cell carcinoma (OSCC) therapy. Upregulation of keratin 16 (KRT16) was found by comparing isogenic...
Saved in:
Published in | Journal of experimental & clinical cancer research Vol. 38; no. 1; pp. 89 - 17 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
19.02.2019
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!